Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I hear you! That's an old-school phrase. Haha
Kaboom and Happy 2017! May great things come for PMCB and all of its supporters!!!
Yes, our Principal Investigator... :)
Really good article, thanks...
A nice reminder, thanks...
"But with the prospect of large trials looming down the road, the company also is assessing the interest of big pharmas, and many have signed nondisclosure agreements. " Ken Waggoner
http://www.bioworld.com/content/pharmacyte-seeks-solve-pancreas-puzzle-cell-box
"The value increase after the trial will be 10 fold the impact of the dilution."
I agree with you Gmc2020.
Thanks, you too Kimora...
So many committed longs here. I have been here since Feb 2014. Nice to see you posting. CiaB has quite the following. ')
You are making me blush.
Haha. Happy Christmas!
Appreciate you as well, B. So many great folks here...
Merry Christmas... Enjoy your loved ones...
Cool. Thanks
Thanks K. I am having trouble translating it because some of it is in English and it seems that Google can't get that most of it is in German. I will keep trying because it looks like great info...
There are those who have been trading this for years. Hopefully, we can shake them off soon...
Thanks Rudy...
OK, one more. "Dr. Matthias Löhr recently commented on the technology, the trial design and the team that will be involved with the trial. In my opinion, we couldn't be in better shape at this point. All of the pieces are falling into place quite nicely."
:)
"We've come a long way since I took over in January 2014. Now that we're at the FDA, it's extremely satisfying and exciting. But being there is just another new beginning. We are fully committed to seeing this technology validated so that we can be but a small part of a very long journey in changing how solid cancerous tumors will be treated in the future." KW
"Waggoner said that the one thing he's constantly thinking about is the infinite possibilities for his company's platform technology Cell-in-a-Box® to treat so many forms of solid tumor cancers -- liver, breast, ovarian -- to name a few."
"The key is to get the trial underway and validate our therapy for pancreatic cancer." KW
#FFO
Congratulations Longs! "We are fortunate that our shareholders saw the value proposition in the company to invest at a level that enables us to once again qualify to use this source of capital. Small biotech companies often run out of money before their products even get a chance to succeed, and this funding opportunity goes a long way in minimizing that possibility..." KW
Getting CiaB to patients is of utmost importance...
#FFO... Nice, Bio...
I was just telling Pete the same thing and I am especially looking forward to CiaB helping to improve the quality of life for patients. That is what I have been waiting for in addition to the value we will finally realize for our investment. :)
So true, Pete. We have a very supportive team of longs. But the real celebration will be when we hear the benefits of this technology for patients. With that good news, we will all be rewarded. We just have to remain vigilant.
This has been a roller coaster ride for sure and it is so nice being on an incline. Happy for all longs, especially you, Pete. You are so dedicated and a great supporter of $PMCB.
GLT us all!
Nice...
I think you have hit the nail on the head! Holding for a cure...
It's not the company. It is the process of getting drug approval that takes a long time. But, imvho, it is lack of patience that is the loser... The winners are on the side of Cell-in-a-Box technology, imo...
Yes, traders will move on but investors will be here and accumulating...
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=125443764
Very nice...
Thanks Pete... So many smart longs here that I have learned so much from as well. The technology is not difficult to understand and has already been tested. We have a great team backing us and now the FDA has agreed to meet with us... Exciting times, Pete.
By far, for sure... I believed that before we even got FDA ODD but the major hurdles have now been overcome, imo. Dr. Von Hoff and his team are very familiar with working with the FDA for drug approval and his partner, Dr. Hidalgo is the PI. What more could we want? Have been so looking forward to helping patients and we are so close, Bio...
Such an easy call, imo, Pete...
What a nice compliment... Thank you and your words of wisdom are also always appreciated. To get this far with the team we have, the risk is looking less risky to me... As we have always agreed, the pps is not reflective of the true value of Cell-in-a-Box's potential for multiple treatments. Now is the time I intend to accumulate as much as I can.... All investments are risky but I really like the chances for CiaB....
Pre-IND meeting is good news and is a major milestone achievement. A drop in price fo me, at is point, is a signal to buy as much as I can. Just put in my order...
I am as well. Will be three years for me in March 2017. So glad I have been able to be patient and have the support of many other longs. I think we may be blessed in the end if we can sustain our commitment to see this through trials... KW is clearly doing his part...
I have thought CELG is interested in this technology for a while now. Keeps getting more interesting with every PMCB step forward.
So true and so worth the wait. Thanks...
Promised Land... So excited about next steps, starting trials and seeing this revolutionary technology change lives!
Exciting times, efood...
Yes, efood. There is no doubt he is accomplished. We are at the door of starting trials for an unmet need with a team of world renowned doctors. We have come a long way with KW at the helm..
This is the kind of follow-up I like to see... "When I started to lead this company in January 2014, my first goal was to surround our technology with the best of the best in the biotech sector. I believe we have more than accomplished this goal as we have compiled an internationally renowned team that will lead PharmaCyte into what we expect to be a pivotal human clinical trial. My second goal was to get our therapy to the FDA, and with this pre-IND meeting request, we have accomplished this goal as well. My ultimate goal, of course, was and is to get our pancreatic cancer therapy into clinical trials and approved by the FDA. I feel we are well on our way to accomplishing this goal.”
Priorities...